Literature DB >> 23891238

Immunosurveillance as a regulator of tissue homeostasis.

Laura Senovilla1, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer.   

Abstract

The immune system is intimately involved in the pathophysiology of several human disorders. Thus, excessive or chronic inflammation initiated by numerous insults exacerbates tissue damage and - at least in some settings - promotes oncogenesis. Nevertheless, immunosurveillance, the process whereby the immune system eliminates damaged, senescent and (pre-)malignant cells, appears to exert major homeostatic functions. Accumulating evidence indicates that defects in the molecular and cellular circuitries that underpin immune responses accelerate the course of chronic diseases, including hepatic cirrhosis and cancer. Along similar lines, the re-establishment of tissue homeostasis upon acute pathological insults such as ischemia appears to be delayed when normal immunological functions are naturally or experimentally compromised. Here, we propose that immunosurveillance is a key regulator of tissue homeostasis.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  aging; cancer; dendritic cells; immunopeptidome; natural killer cells; senescence

Mesh:

Year:  2013        PMID: 23891238     DOI: 10.1016/j.it.2013.06.005

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  30 in total

Review 1.  A Believer's Overview of Cancer Immunosurveillance and Immunotherapy.

Authors:  Olivera J Finn
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

Review 2.  Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.

Authors:  Frederik Soetaert; Preethi Korangath; David Serantes; Steven Fiering; Robert Ivkov
Journal:  Adv Drug Deliv Rev       Date:  2020-06-27       Impact factor: 15.470

Review 3.  Pathogenesis of cerebral palsy through the prism of immune regulation of nervous tissue homeostasis: literature review.

Authors:  Natalya Lisovska; Zholtay Daribayev; Yevgeny Lisovskyy; Kenzhe Kussainova; Lana Austin; Sholpan Bulekbayeva
Journal:  Childs Nerv Syst       Date:  2016-09-14       Impact factor: 1.475

4.  Dichotomous roles for externalized cardiolipin in extracellular signaling: Promotion of phagocytosis and attenuation of innate immunity.

Authors:  Krishnakumar Balasubramanian; Akihiro Maeda; Janet S Lee; Dariush Mohammadyani; Haider Hussain Dar; Jian Fei Jiang; Claudette M St Croix; Simon Watkins; Vladimir A Tyurin; Yulia Y Tyurina; Katharina Klöditz; Anastassia Polimova; Valentyna I Kapralova; Zeyu Xiong; Prabir Ray; Judith Klein-Seetharaman; Rama K Mallampalli; Hülya Bayir; Bengt Fadeel; Valerian E Kagan
Journal:  Sci Signal       Date:  2015-09-22       Impact factor: 8.192

Review 5.  Mosaic loss of human Y chromosome: what, how and why.

Authors:  Xihan Guo; Xueqin Dai; Tao Zhou; Han Wang; Juan Ni; Jinglun Xue; Xu Wang
Journal:  Hum Genet       Date:  2020-02-04       Impact factor: 4.132

6.  Age-Associated Resident Memory CD8 T Cells in the Central Nervous System Are Primed To Potentiate Inflammation after Ischemic Brain Injury.

Authors:  Rodney M Ritzel; Joshua Crapser; Anita R Patel; Rajkumer Verma; Jeremy M Grenier; Anjali Chauhan; Evan R Jellison; Louise D McCullough
Journal:  J Immunol       Date:  2016-03-09       Impact factor: 5.422

7.  Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency.

Authors:  Musa AlHarbi; Nahla Ali Mobark; Latifa AlMubarak; Rasha Aljelaify; Mariam AlSaeed; Amal Almutairi; Fatmah Alqubaishi; M Emarat Hussain; Ali Abdullah O Balbaid; Amal Said Marie; Lamia AlSubaie; Saeed AlShieban; Nada alTassan; Shakti H Ramkissoon; Malak Abedalthagafi
Journal:  Oncologist       Date:  2018-08-13

8.  Immune effectors responsible for the elimination of hyperploid cancer cells.

Authors:  Fernando Aranda; Kariman Chaba; Norma Bloy; Pauline Garcia; Chloé Bordenave; Isabelle Martins; Gautier Stoll; Antoine Tesniere; Guido Kroemer; Laura Senovilla
Journal:  Oncoimmunology       Date:  2018-05-21       Impact factor: 8.110

Review 9.  Trial Watch: Peptide-based anticancer vaccines.

Authors:  Jonathan Pol; Norma Bloy; Aitziber Buqué; Alexander Eggermont; Isabelle Cremer; Catherine Sautès-Fridman; Jérôme Galon; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-01-09       Impact factor: 8.110

10.  Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma.

Authors:  E T Wong; E Lok; S Gautam; K D Swanson
Journal:  Br J Cancer       Date:  2015-06-30       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.